Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-002960

Chief Legal Officer & Corp Sec acquired 99,133 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Derek M Chief Legal Officer & Corp Sec 2026-01-16 Grant or award +99,133 182,933 D
Derivatives
Meisner Derek M Chief Legal Officer & Corp Sec 2026-01-16 Grant or award · Employee Stock Option (right to buy) +148,700 148,700 D
Loading xslF345X05/wk-form4_1769038296.xml…